Universal Health Services, Inc. (UHS) SEC Filings & Earnings Calls
EquiReason read 18 Universal Health Services, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-21 — UHS issued senior secured notes (5.500% due 2031, 6.000% due 2036) via supplemental indentures, creating a direct financial obligation..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 11.0B
- P/E TTM
- 7.6
- Dividend yield
- 0.4%
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
21 Aug 20268-K · 1.01, 2.03UHS issued senior secured notes (5.500% due 2031, 6.000% due 2036) via supplemental indentures, creating a direct financial obligation.open
Risks flagged
Increased leverage from new senior secured notes issuance
“Issuance of 5.500% and 6.000% senior secured notes due 2031 and 2036 respectively”
17 Aug 20268-K · 2.03, 8.01Universal Health Services completes acquisition of Talkspace for $5.25 per share in cash, financed with $400M DDTL and revolver borrowings. Talkspace becomes indirect wholly-owned subsidiary.acquisitionopen
Figures in the filing · each found in the filing text
| Acquisition price per share · Q3-2026 | $5.25 | |
| DDTL Facility borrowed · Q3-2026 | $400M |
13 Aug 20268-K · 1.01UHS issued $1.1B senior secured notes in two tranches ($600M 5.5% due 2031, $500M 6.0% due 2036) via underwriting agreement; proceeds used to repay revolver and possibly fund Talkspace acquisition.open
Risks flagged
Increased leverage from $1.1B in new secured debt; interest expense will rise.
“$1,100,000,000 aggregate principal amount of senior secured notes at 5.5% and 6.0%” · word for word
7 Aug 202610-QUHS reported Q2 2026 net revenue of $4.638B (+8.3% YoY) and net income attributable to UHS of $358M (+1.5% YoY), with operating margin declining 60 bps.earningsopen
Figures in the filing · each found in the filing text
| Net revenues · Q2-2026 | $4.64B | +8% y/y |
| Net income attributable to UHS · Q2-2026 | $358M | +1% y/y |
| Income from operations · Q2-2026 | $517M | +3% y/y |
| Acute care same-facility net revenue · Acute Care Hospital Services · Q2-2026 | $2.51B | +8% y/y |
| Acute care same-facility income before income taxes · Acute Care Hospital Services · Q2-2026 | $246M | +7% y/y |
| Behavioral health same-facility net revenue · Behavioral Health Care Services · Q2-2026 | $1.93B | +7% y/y |
| Behavioral health same-facility income before income taxes · Behavioral Health Care Services · Q2-2026 | $427M | +9% y/y |
| Total uncompensated care · Acute Care Hospital Services · Q2-2026 | $1.26B | +36% y/y |
| Estimated cost of providing uncompensated care · Acute Care Hospital Services · Q2-2026 | $107M | +30% y/y |
Risks flagged
Medicaid Funding Reduction
“Under current law, and based on our current expectations, we estimate that, commencing with the 2028 state fiscal years, our aggregate annual net benefit will be reduced, on an annually increasing and relatively pro rata basis, by approximately $500 million by 2032.” · word for word
Interest Rate Risk
“Our $700 million, 1.65% senior notes ("2026 Notes") mature on September 1, 2026. Market interest rates have increased significantly since the 2026 Notes were issued in 2021. We expect that we will refinance the 2026 Notes at significantly higher interest rates which will significantly increase our interest expense thereby decreasing our net income attributab”
Labor Cost and Staffing Risk
“At certain facilities, particularly within our behavioral health care segment, there have been occasions when we were unable to fill all vacant positions and, consequently, we were required to limit patient volumes.” · word for word
Tariff Risk
“Significant tariffs or other restrictions, if imposed on our imported pharmaceutical ingredients, medical devices, medical equipment and their ingredients and components, or otherwise on our suppliers, could escalate costs of medications, medical devices and medical equipment and disrupt our supply chains.” · word for word
Acquisition Integration Risk
“The acquisition is subject to numerous risks and uncertainties including uncertainty as to whether the parties will be able to complete the merger on the terms set forth in the merger agreement” · word for word
28 Jul 20268-K · 2.02Net Revenues $4.64B (+8% y/y); Net Income Attributable to UHS $358M (+2% y/y); Diluted EPS $5.98 (+10% y/y); Guidance: Revised 2026 full-year operating results forecast upwardearningsopen
Figures in the filing · each found in the filing text
| Net Revenues · Q2-2026 | $4.64B | +8% y/y |
| Net Income Attributable to UHS · Q2-2026 | $358M | +2% y/y |
| Diluted EPS · Q2-2026 | $5.98 | +10% y/y |
| Adjusted EBITDA net of NCI · Q2-2026 | $678M | +5% y/y |
| Same-Facility Adjusted Admissions Growth · Acute Care · Q2-2026 | 2.9% | |
| Same-Facility Net Revenue per Adjusted Admission Growth · Acute Care · Q2-2026 | 3.0% |
Guidance
Revised 2026 full-year operating results forecast upward
Company revises 2026 full-year forecast upward, indicating confidence in continued strong performance
Risks flagged
Medicaid directed payment program dependency; $72M favorable impact in Q2
“Favorable net pre-tax impact of $72M from Florida Medicaid program and reserve adjustment”
21 Jul 20268-K · 1.01, 2.03UHS entered a Twelfth Amendment to its Credit Agreement, adding a $700M incremental delayed draw term loan facility (364-day maturity) for general corporate purposes, including refinancing.open
Risks flagged
Increased leverage; secured debt obligations.
“The obligations are secured on an equal ratable basis with existing senior secured notes.”
21 May 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Potential disruption in Behavioral Health division leadership; search for permanent replacement underway.
“Item 5.02: resignation of President, Behavioral Health; CEO interim; immediate search for replacement.”
7 May 202610-QNet revenues $4.50B (+10% y/y); Net income attributable to UHS $349M (+10% y/y); Income from operations $503M (+11% y/y)open
Figures in the filing · each found in the filing text
| Net revenues · Q1-2026 | $4.50B | +10% y/y |
| Net income attributable to UHS · Q1-2026 | $349M | +10% y/y |
| Income from operations · Q1-2026 | $503M | +11% y/y |
| Acute care Same Facility net revenues · Acute Care Hospital Services · Q1-2026 | $2.47B | +8% y/y |
| Behavioral health Same Facility net revenues · Behavioral Health Care Services · Q1-2026 | $1.82B | +7% y/y |
| Acute care Same Facility income before income taxes · Acute Care Hospital Services · Q1-2026 | $303M | +14% y/y |
| Behavioral health Same Facility income before income taxes · Behavioral Health Care Services · Q1-2026 | $366M | +8% y/y |
| Acute care Same Facility salaries, wages and benefits as % of net revenues · Acute Care Hospital Services · Q1-2026 | 38.6% | |
| Behavioral health Same Facility salaries, wages and benefits as % of net revenues · Behavioral Health Care Services · Q1-2026 | 54.6% | |
| Acute care Same Facility inpatient admissions · Acute Care Hospital Services · Q1-2026 | 86,780 | -2% y/y |
Risks flagged
Medicaid funding reduction
“we estimate that, commencing with the 2028 state fiscal years, our aggregate annual net benefit will be reduced, on an annually increasing and relatively pro rata basis, by approximately $432 million to $480 million by 2032.” · word for word
Debt refinancing risk
“Our $700 million, 1.65% senior notes ("2026 Notes") mature on September 1, 2026. Market interest rates have increased significantly since the 2026 Notes were issued in 2021. We expect that we will refinance the 2026 Notes at significantly higher interest rates which will significantly increase our interest expense thereby decreasing our net income attributab” · word for word
Tariff cost escalation
“significant tariffs or other restrictions, if imposed on our imported pharmaceutical ingredients, medical devices, medical equipment and their ingredients and components, could escalate costs of medications, medical devices and medical equipment and disrupt our supply chains.” · word for word
Labor cost inflation
“we have experienced inflationary pressures, primarily in personnel costs, although those pressures have moderated more recently.” · word for word
Acquisition integration risk
“The acquisition is subject to numerous risks and uncertainties including uncertainty as to whether the parties will be able to complete the merger on the terms set forth in the merger agreement.” · word for word
28 Apr 20268-K · 2.02UHS reported Q1 2026 net income $348.7M ($5.65/diluted) vs $316.7M ($4.80) YoY; net revenues +9.6% to $4.495B; adjusted EBITDA $648.3M vs $598.2M; acute care same-facility revenue +8.2%, behavioral +7.3%; operating cash flow $402M vs $360M;earningsopen
Figures in the filing · each found in the filing text
| Net revenues · Q1-2026 | $4.50B | +10% y/y |
| Net income attributable to UHS · Q1-2026 | $349M | +10% y/y |
| Adjusted EBITDA net of NCI · Q1-2026 | $648M | +8% y/y |
| Net cash provided by operating activities · Q1-2026 | $402M | +12% y/y |
| Adjusted diluted EPS · Q1-2026 | $5.62 | +16% y/y |
| Acute care same-facility net revenue per adjusted admission · Acute Care · Q1-2026 | 6.3% | |
| Behavioral same-facility net revenue per adjusted admission · Behavioral Health · Q1-2026 | 6.2% | |
| Behavioral same-facility adjusted admissions change · Behavioral Health · Q1-2026 | 1.2% | |
| Shares repurchased · Q1-2026 | 675,000 |
Risks flagged
Medicaid supplemental payment delays could impact cash flow timing
“Favorable change of $95 million in accounts receivable due, in part, to delays experienced during the first quarter of 2025 in receipt of funds in connection with certain Medicaid supplemental payment programs in various states.” · word for word
Working capital volatility from accounts payable timing
“Unfavorable change of $80 million in other working capital accounts due primarily to the timing of accounts payable disbursements.” · word for word
24 Apr 20268-K · 1.01, 2.03UHS entered into an Eleventh Amendment and Increased Facility Activation Notice to its Senior Secured Credit Facility, and executed supplemental indentures for existing notes, indicating refinancing and extension of debt maturities.open
Risks flagged
Increased leverage from new debt; financial covenants based on consolidated net leverage ratio.
“Item 1.01: applicable margin based on Consolidated Net Leverage Ratio; financial covenants.”
9 Apr 2026DEF 14AAnnual proxy statement disclosing executive compensation structure, pay-for-performance alignment, and governance details for 2026 annual meeting.open
Figures in the filing · each found in the filing text
| Consolidated net revenues · FY2025 | $17.36B | +10% y/y |
| Adjusted net income attributable to UHS · FY2025 | $1.40B | +24% y/y |
| Adjusted net income attributable to UHS, per diluted share · FY2025 | $21.74 | +31% y/y |
| Net revenues - Acute care services, same facility basis · Acute Care Services · FY2025 | $9.32B | +9% y/y |
| Net revenues - Behavioral health care services, same facility basis · Behavioral Health Care Services · FY2025 | $7.19B | +8% y/y |
| Capital expenditures - Acute care services · Acute Care Services · FY2025 | $642M | -2% y/y |
| Capital expenditures - Behavioral health care services · Behavioral Health Care Services · FY2025 | $358M | +25% y/y |
| Repurchase of common shares · FY2025 | $899M | +50% y/y |
| Adjusted EBITDA net of NCI · FY2025 | $2.59B | |
| Net income attributable to UHS · FY2025 | $1.49B | +30% y/y |
Risks flagged
Dual-class voting structure entrenchment risk
“UHS officers and directors have only 16% of the ownership of UHS yet have 91% of the voting power.” · word for word
Concentrated control by founder family
“Alan B. Miller holds 88.9% of general voting power; the family of Alan B. Miller holds more than 95% of the shares of Class A and Class C Common Stock, which is entitled to elect 80% of the entire Board of Directors and constitutes more than 50% of our aggregate voting power.”
Regulatory and reimbursement risk
“dependence on payments from the government and other third party payers, including potential changes resulting from the 2024 elections such as legislation to significantly reduce federal Medicaid funding” · word for word
30 Mar 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
No material risk signals identified; filing relates to routine executive compensation arrangements.
26 Feb 20268-K · 2.02, 8.01Net Revenue $4.49B (+9% y/y); Net Revenue $17.36B (+10% y/y); Net Income Attributable to UHS $446M; Guidance: Provides FY2026 operating results forecastearningsopen
Figures in the filing · each found in the filing text
| Net Revenue · Q4-2025 | $4.49B | +9% y/y |
| Net Revenue · FY2025 | $17.36B | +10% y/y |
| Net Income Attributable to UHS · Q4-2025 | $446M | |
| Net Income Attributable to UHS · FY2025 | $1.49B | |
| Adjusted Net Income Attributable to UHS · Q4-2025 | $371M | |
| Adjusted Net Income Attributable to UHS · FY2025 | $1.40B | |
| Adjusted EBITDA net of NCI · Q4-2025 | $679M | |
| EBITDA net of NCI · Q4-2025 | $785M | |
| Legal Reserve · Q3-2025 | $18M |
Guidance
Provides FY2026 operating results forecast
Company provides FY2026 forecast, indicating confidence in continued operational performance.
Risks flagged
Significant litigation risk: $500M punitive damages verdict overturned but new trial ordered; potential financial exposure.
“jury also awarded punitive damages against UHS of Delaware, Inc. of $500 million; judge issued a verbal order granting a new trial based upon juror misconduct; recorded an $18 million legal reserve” · word for word
25 Feb 202610-KGoodwill $4.00B; Stock repurchases $899M; Remaining stock repurchase authorization $1.43B; Guidance: Estimated annual net benefit reduction of $432M-$480M by 2032 from Medicaid legislation; $700M notes to be refinanced at higher ratesopen
Figures in the filing · each found in the filing text
| Goodwill · 2025-12-31 | $4.00B | |
| Stock repurchases · FY2025 | $899M | |
| Remaining stock repurchase authorization · 2025-12-31 | $1.43B | |
| 2026 Notes outstanding · 2025-12-31 | $700M | |
| Remaining commercial insurance coverage (2020 policy year) · 2025-12-31 | $143M |
Guidance
Estimated annual net benefit reduction of $432M-$480M by 2032 from Medicaid legislation; $700M notes to be refinanced at higher rates
Significant headwinds from Medicaid funding cuts, litigation, and refinancing risk; share repurchase program provides some offset.
Risks flagged
Medicaid funding reduction
“Under current law, and based on our current expectations, we estimate that, commencing with the 2028 state fiscal years, our aggregate annual net benefit will be reduced, on an annually increasing and relatively pro rata basis, by approximately $432 million to $480 million by 2032.” · word for word
Litigation exposure
“A jury entered a verdict finding Dr. Davidow and Cumberland liable and awarded these three plaintiffs combined compensatory damages of $60 million ... an additional combined $180 million in trebled damages for violation of the VCPA, and an additional combined $120 million in punitive damages.” · word for word
Interest rate refinancing risk
“We expect that we will refinance the 2026 Notes at significantly higher interest rates which will significantly increase our interest expense thereby decreasing our net income attributable to UHS.” · word for word
Tariff impact on supply chain
“If significant tariffs or other restrictions are imposed on our imported pharmaceutical ingredients, medical devices, medical equipment and their ingredients and components, there could be significant strain on our supply chains, causing major disruptions in procurement processes and contract negotiations with suppliers due to increased costs.” · word for word
Insurance coverage deterioration
“Effective March, 2025, our excess commercial insurance coverage for professional and general liability claims contains less favorable terms than previous years including coverage exclusions for incidents involving sexual molestation or abuse, higher premiums and lower aggregate limitations.” · word for word
7 Nov 202510-QUHS reported strong Q3 2025 results with revenue +13.4%, operating margin expansion, and net income +44%, driven by volume growth, pricing, and labor cost moderation.earningsopen
Figures in the filing · each found in the filing text
| Net revenues · Q3-2025 | $4.50B | +13% y/y |
| Net revenues · 9M-2025 | $12.88B | +10% y/y |
| Net income attributable to UHS · Q3-2025 | $373M | +44% y/y |
| Net income attributable to UHS · 9M-2025 | $1.04B | +29% y/y |
Risks flagged
Medicaid policy risk
“Legislation adopted on July 4, 2025 attaches work and community service requirements to eligibility for Medicaid benefits that will have the effect of limiting Medicaid enrollment and expenditures and the legislation also places limits on provider taxes used to increase federal Medicaid funding to states.” · word for word
Litigation risk
“An $18 million legal reserve established during the third quarter of 2025 in connection with the verdict in the Pinnacle litigation in Washoe County, Nevada, against certain subsidiaries of ours.” · word for word
Liability reserve risk
“As a result of unfavorable trends experienced, included in our results of operations were increases to our reserves for self-insured professional and general liability claims amounting to $35 million during each of the three and nine-month periods ended September 30, 2025.” · word for word
Federal government shutdown risk
“Currently, the United States Congress has failed to approve a federal budget for federal fiscal year 2026 and a federal shutdown began on October 1, 2025.” · word for word
28 Oct 20258-K · 2.02Net income attributable to UHS $373M (+44% y/y); Diluted earnings per share $5.86 (+54% y/y); Net revenues $4.50B (+13% y/y); Guidance: Increased full-year 2025 operating results forecast; $1.5B buyback authorization increaseearningsopen
Figures in the filing · each found in the filing text
| Net income attributable to UHS · Q3-2025 | $373M | +44% y/y |
| Diluted earnings per share · Q3-2025 | $5.86 | +54% y/y |
| Net revenues · Q3-2025 | $4.50B | +13% y/y |
| Adjusted net income attributable to UHS · Q3-2025 | $362M | +44% y/y |
| Adjusted diluted earnings per share · Q3-2025 | $5.69 | +53% y/y |
| EBITDA net of NCI · Q3-2025 | $684M | +29% y/y |
| Adjusted EBITDA net of NCI · Q3-2025 | $671M | +27% y/y |
| Acute care same-facility adjusted admissions growth · Acute Care · Q3-2025 | 2.0% | |
| Acute care same-facility net revenue per adjusted admission growth · Acute Care · Q3-2025 | 9.8% | |
| Acute care same-facility net revenue growth · Acute Care · Q3-2025 | 12.8% |
Guidance
Increased full-year 2025 operating results forecast; $1.5B buyback authorization increase
Raised FY2025 operating forecast due to strong Q3 results; also announced $1.5B increase in stock repurchase authorization.
Risks flagged
Pre-tax charge of $35M to increase self-insured professional and general liability reserves due to unfavorable claims trends.
“a $35 million pre-tax charge incurred to increase our reserves for self-insured professional and general liabilities resulting from unfavorable claims' trends” · word for word
Universal Health Services, Inc. — questions
- What did Universal Health Services, Inc. file recently?
- 18 SEC filings in the last 12 months. Latest: 8-K on 2026-08-21 — UHS issued senior secured notes (5.500% due 2031, 6.000% due 2036) via supplemental indentures, creating a direct financial obligation.
Every figure on this page comes from Universal Health Services, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.